|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0009498,
umls-concept:C0009510,
umls-concept:C0024198,
umls-concept:C0030705,
umls-concept:C0041703,
umls-concept:C0205178,
umls-concept:C0241407,
umls-concept:C1412999,
umls-concept:C1514468,
umls-concept:C1534709,
umls-concept:C2745888
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2008-6-13
|
|
pubmed:abstractText |
Current laboratory markers do not readily detect acute Lyme disease. We assessed the utility of complement and its split products as markers of Lyme disease in patients shortly after a tick bite.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1423-0097
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
(c) 2008 S. Karger AG, Basel
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
146
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
255-61
|
|
pubmed:meshHeading |
pubmed-meshheading:18270493-Adolescent,
pubmed-meshheading:18270493-Adult,
pubmed-meshheading:18270493-Aged,
pubmed-meshheading:18270493-Animals,
pubmed-meshheading:18270493-Borrelia burgdorferi,
pubmed-meshheading:18270493-Complement Activation,
pubmed-meshheading:18270493-Complement C3a,
pubmed-meshheading:18270493-Complement C4a,
pubmed-meshheading:18270493-Erythema Chronicum Migrans,
pubmed-meshheading:18270493-Female,
pubmed-meshheading:18270493-Humans,
pubmed-meshheading:18270493-Insect Bites and Stings,
pubmed-meshheading:18270493-Lyme Disease,
pubmed-meshheading:18270493-Male,
pubmed-meshheading:18270493-Middle Aged,
pubmed-meshheading:18270493-Statistics, Nonparametric
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Complement split products C3a and C4a are early markers of acute lyme disease in tick bite patients in the United States.
|
|
pubmed:affiliation |
Center for Research on Biotoxin Associated Illnesses, Pocomoke, Md., USA.
|
|
pubmed:publicationType |
Journal Article
|
